XML 49 R36.htm IDEA: XBRL DOCUMENT v3.25.1
SHAREHOLDERS’ DEFICIT (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
May 31, 2023
Dec. 31, 2024
May 22, 2024
Apr. 16, 2024
Mar. 01, 2024
Dec. 31, 2023
Oct. 31, 2023
May 18, 2023
Class of Stock [Line Items]                
Preference shares, shares authorized   5,000,000       5,000,000    
Preference shares, par value   $ 0.0001       $ 0.0001    
Preference shares, shares outstanding   0       0    
Preference shares, shares issued   0       0    
Shares issued, price per share   $ 11.43            
Common Stock [Member]                
Class of Stock [Line Items]                
Shares issued, price per share     $ 11.24         $ 10.55
Aspire Biopharma Inc [Member]                
Class of Stock [Line Items]                
Common stock, shares authorized 750,000,000 750,000,000       750,000,000    
Common stock, parvalue per share   $ 0.00005       $ 0.00005    
Common stock, shares outstanding   440,000,000       440,000,000    
Stockholders equity note stock split conversion ratio 20:1              
Number of warrants issued   44,000,000       7,500,000    
Exercise price of warrants   $ 0.40       $ 0.02    
Warrants outstanding   $ 91,500,000       $ 47,500,000    
Aspire Biopharma Inc [Member] | Common Stock [Member]                
Class of Stock [Line Items]                
Common stock, parvalue per share   $ 0.001            
Common Class A [Member]                
Class of Stock [Line Items]                
Common stock, shares authorized   300,000,000       300,000,000    
Common stock, parvalue per share   $ 0.0001       $ 0.0001    
Common stock, shares outstanding   7,187,500       7,187,500    
Common Class A Subject to Redemption [Member]                
Class of Stock [Line Items]                
Temporary Equity, Shares Outstanding   577,644       1,803,729    
Ordinary shares subject to possible redemption, shares issued   577,644       1,803,729    
Common Class B [Member]                
Class of Stock [Line Items]                
Common stock, shares authorized   50,000,000       50,000,000    
Common stock, parvalue per share   $ 0.0001       $ 0.0001    
Common stock, shares outstanding   0       0    
Ratio to be applied to the stock in the conversion   20.00%            
Series A Preferred Stock [Member] | Aspire Biopharma Inc [Member]                
Class of Stock [Line Items]                
Preference shares, shares authorized   25,000,000         25,000,000  
Preference shares, par value   $ 0.0001         $ 0.0001  
Preference shares, shares outstanding   322,059       0    
Preference shares, shares issued       35,702 286,357      
Shares issued, price per share       $ 0.80 $ 0.80